Current landscape and future directions of bispecific antibodies in cancer immunotherapy

Recent advances in cancer immunotherapy using monoclonal antibodies have dramatically revolutionized the therapeutic strategy against advanced malignancies, inspiring the exploration of various types of therapeutic antibodies. Bispecific antibodies (BsAbs) are recombinant molecules containing two di...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jing, Yang, Yueyao, Wang, Gang, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650279/
https://www.ncbi.nlm.nih.gov/pubmed/36389699
http://dx.doi.org/10.3389/fimmu.2022.1035276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650279/
https://www.ncbi.nlm.nih.gov/pubmed/36389699
http://dx.doi.org/10.3389/fimmu.2022.1035276

Ejemplares similares